 | Up a level |
Hayrapetyan, Liana; Bouteiller, Sofiane; Quintin, Aurélie; Riedo, Rahel; Degen, Peter; Aebersold, Daniel; Medo, Matúš; Adamantidis, Antoine; Levitt, Pat; Zimmer, Yitzhak; Medova, Michaela (2023). MICE LACKING A NOVEL PHOSPHOSITE S1014 ON THE MET RECEPTOR TYROSINE KINASE DISPLAY ASD-ASSOCIATED BEHAVIORAL PATTERN. IBRO neuroscience reports, 15(S1), S99-S99. Elsevier 10.1016/j.ibneur.2023.08.079
Koch, Jonas P; Roth, Selina M; Quintin, Aurélie; Gavini, Jacopo; Orlando, Eleonora; Riedo, Rahel; Pozzato, Chiara; Hayrapetyan, Liana; Aebersold, Ruedi; Stroka, Deborah M; Aebersold, Daniel M; Medo, Matúš; Zimmer, Yitzhak; Medova, Michaela (2023). A DNA-PK phosphorylation site on MET regulates its signaling interface with the DNA damage response. Oncogene, 42(26), pp. 2113-2125. Nature Publishing Group 10.1038/s41388-023-02714-6
Orlando, Eleonora; Medo, Matúš; Bensimon, Ariel; Quintin, Aurélie; Riedo, Rahel; Roth, Selina M; Riether, Carsten; Marti, Thomas M; Aebersold, Daniel M; Medová, Michaela; Aebersold, Ruedi; Zimmer, Yitzhak (2023). Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. Cellular and molecular life sciences : CMLS, 80(4), p. 85. Springer 10.1007/s00018-023-04725-8
Orlando, Eleonora; Medo, Matúš; Bensimon, Ariel; Quintin, Aurélie; Riedo, Rahel; Roth, Selina M; Riether, Carsten; Marti, Thomas M; Aebersold, Daniel M; Medova, Michaela; Aebersold, Ruedi; Zimmer, Yitzhak; quintin, a (2022). An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. Cellular and molecular life sciences : CMLS, 80(1), p. 6. Springer 10.1007/s00018-022-04634-2
Bosch-Guiteras, Núria; Uroda, Tina; Guillen-Ramirez, Hugo A.; Riedo, Rahel; Gazdhar, Amiq; Esposito, Roberta; Pulido-Quetglas, Carlos; Zimmer, Yitzhak; Medová, Michaela; Johnson, Rory (2021). Enhancing CRISPR deletion via pharmacological delay of DNA-PKcs. Genome research, 31(3), pp. 461-471. Cold Spring Harbor, N.Y 10.1101/gr.265736.120
Bensimon, Ariel; Koch, Jonas P.; Francica, Paola; Roth, Selina M.; Riedo, Rahel; Glück, Astrid A.; Orlando, Eleonora; Blaukat, Andree; Aebersold, Daniel M.; Zimmer, Yitzhak; Aebersold, Ruedi; Medová, Michaela (2020). Deciphering MET-dependent modulation of global cellular responses to DNA damage by quantitative phosphoproteomics. Molecular oncology, 14(6), pp. 1185-1206. Elsevier 10.1002/1878-0261.12696
Riedo, Rahel; Pilarski, Julia; Elicin, Olgun; Aebersold, D. M.; Stoycheva, Diana; Carl, Sarah; Medova, Michaela (18 September 2023). Immune signature to predict early toxicities of head and neck squamous cell carcinoma patients following multimodal therapy. Strahlentherapie und Onkologie, 11(199), p. 1043. Springer
Hayrapetyan, Liana; Bouteiller, Sofiane; Quintin, Aurélie; Riedo, Rahel; Degen, Peter Methys; Aebersold, Daniel Matthias; Medo, Matúš; Adamantidis, Antoine Roger; Levitt, Pat; Zimmer, Yitzhak; Medova, Michaela (2023). Mice Lacking a Novel Phosphosite on MET Display ASD-Associated Behavior Pattern (Unpublished). In: Annual meeting of the Swiss Society for Neuroscience. Lugano, Switzerland. 09. – 10.06.2023.
Pozzato, Chiara; Koch, Jonas Paul; Riedo, Rahel; Hayrapetyan, Liana; Medo, Matúš; Aebersold, Daniel Matthias; Zimmer, Yitzhak; Medova, Michaela (2023). A newly discovered phosphorylation site of the MET receptor tyrosine kinase, Ser1016, in mediating tumour growth and cancer therapy resistance. (Unpublished). In: BCRC Retreat. Bern, Switzerland. 26.06.2023.
Hayrapetyan, Liana; Degen, Peter Methys; Bouteiller, Sofiane; Riedo, Rahel; Quintin, Aurélie; Aebersold, Daniel Matthias; Medo, Matúš; Adamantidis, Antoine Roger; levitt, pat; Zimmer, Yitzhak; Medova, Michaela (2023). Sex- and strain-dependent dominant behavior in mice lacking the novel S1014 phosphosite on the ASD risk gene MET. (Unpublished). In: Clinical Neuroscience Bern. Bern, Switzerland. 08.09.2023.
